This treatment has the potential of being a game changer in chronic ulcer treatment!
In the era of opioid crisis, topical effective and safe approaches are going transform how we think of managing this type of pain. Great job
Vapogenix has been awarded a $1.5M Phase II SBIR Grant to develop groundbreaking topical therapy for painful inflammatory conditions affecting millions.
@vapogenix There is a real clinical imperative to develop alternatives to opioids for the more than 30 million pat… https://t.co/Fg5t5qYV7M
Great article demonstrating the effectiveness of sevoflurane in treating pain!
Promising news about sevoflurane as a topical treatment for pain! https://t.co/6rGfW6P98n
Going to #JPM2020? @vapogenix CEO Heather Giles, @heather92219925 will be there to talk about our novel non-opioid… https://t.co/Q9knES1rfX
Meet up with Dr. Heather Giles, CEO of Vapogenix Inc at #Pharmacology2019 @BritPharmSoc to learn more about Vapogen… https://t.co/TAvAXvAwos
Vapogenix will be present at the BIO-Europe® 2019 meeting in Hamburg, Germany from November 11th to 13th. We are seeking partners and funding to advance our portfolio programs. For further information: https:// www.vapogenix.co m/news.html#BIOEUROPE2019 #BIO
Vapogenix Team at the Texas Life Science Forum 2019#2019TLSF #BioHouston
Today announced results of Phase II trial of our lead product, VPX638, a topical non-opioid, lidocaine-free analges… https://t.co/WxslEwbqke
Similar Businesses
